Treatment and research Web Team 07/07/2026 Treatment and research Web Team 07/07/2026

CAR T Cells and Lung Cancer: Could This Immunotherapy Become a Future Treatment?

Read More

Prevention and risk Web Team 07/07/2026 Prevention and risk Web Team 07/07/2026

New study adds to changing picture of who develops lung cancer

Read More

Living with lung cancer Web Team 05/07/2026 Living with lung cancer Web Team 05/07/2026

Patient-reported outcomes: asking people with lung cancer how they are

Read More

Treatment and research Web Team 04/07/2026 Treatment and research Web Team 04/07/2026

The Microbiome and Lung Cancer: How Gut Bacteria Could Change Treatment

Read More

Policy and EU affairs, Access to treatment Web Team 01/07/2026 Policy and EU affairs, Access to treatment Web Team 01/07/2026

When care happens is as important as what happens: the case for timed targets in lung cancer

Read More

Lung Cancer Europe and members Web Team 01/07/2026 Lung Cancer Europe and members Web Team 01/07/2026

President’s Mid Year Report: January to June 2026

Lung Cancer Europe's President's Mid Year Report, January to June 2026: our first conference, the 11th Lung Cancer Europe Report and a new Charter.

Read More

Access to treatment Web Team 01/07/2026 Access to treatment Web Team 01/07/2026

Access to Treatment Atlas: compare lung cancer treatment access across Europe

Read More

Lung Cancer Europe and members Web Team 01/07/2026 Lung Cancer Europe and members Web Team 01/07/2026

Lung Cancer Europe updates its identity

Read More

Policy and EU affairs, Access to treatment Web Team 01/07/2026 Policy and EU affairs, Access to treatment Web Team 01/07/2026

What the EU Critical Medicines Act means for lung cancer

Read More

Access to treatment Web Team 01/07/2026 Access to treatment Web Team 01/07/2026

England catches up on cemiplimab for advanced lung cancer

The National Institute for Health and Care Excellence recommends cemiplimab with chemotherapy for advanced lung cancer in England and Wales.

Read More

Treatment and research Web Team 01/07/2026 Treatment and research Web Team 01/07/2026

HARMONi-7: European sites now open for Phase 3 ivonescimab trial in high PD-L1 NSCLC

Read More

Access to treatment, Policy and EU affairs Web Team 30/06/2026 Access to treatment, Policy and EU affairs Web Team 30/06/2026

EU Progress on 2030 Clinical Trial Targets: What It Means for Lung Cancer

Read More

Access to treatment, Policy and EU affairs Web Team 25/06/2026 Access to treatment, Policy and EU affairs Web Team 25/06/2026

Could innovative medicines save more than they cost? What this new report means for lung cancer

Read More

Living with lung cancer Web Team 24/06/2026 Living with lung cancer Web Team 24/06/2026

Lung cancer in women: what a new study shows about treatment side effects

Read More

Prevention and risk Web Team 22/06/2026 Prevention and risk Web Team 22/06/2026

Early-onset lung cancer: why are more younger adults being diagnosed?

Read More

Prevention and risk Web Team 16/06/2026 Prevention and risk Web Team 16/06/2026

Could ageing lung cells increase lung cancer risk?

Read More

Living with lung cancer Web Team 14/06/2026 Living with lung cancer Web Team 14/06/2026

Small cell lung cancer and mental health: experiences reported by Europeans impacted by the disease

Read More

Prevention and risk Web Team 13/06/2026 Prevention and risk Web Team 13/06/2026

Lung cancer in people who have never smoked: what the evidence now shows

Read More

Treatment and research Web Team 12/06/2026 Treatment and research Web Team 12/06/2026

GLP-1 drugs and lung cancer: what the ASCO 2026 evidence shows, and what it does not

Read More

Treatment and research Web Team 11/06/2026 Treatment and research Web Team 11/06/2026

What Could a New Iron Discovery Mean for Lung Cancer Immunotherapy?

New research published in Nature Cancer has identified iron accumulation as a trigger for the destruction of CAR-T immune cells. We explore what this unexpected finding could mean for the future of lung cancer treatment.

Read More